{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T16:09:35Z","timestamp":1732032575259},"reference-count":30,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.intimp.2007.08.021","type":"journal-article","created":{"date-parts":[[2007,11,8]],"date-time":"2007-11-08T12:35:58Z","timestamp":1194525358000},"page":"1668-1677","source":"Crossref","is-referenced-by-count":9,"title":["Decreased ex vivo production of TNF-\u03b1 and IL-8 by peripheral blood cells of patients with rheumatoid arthritis after infliximab therapy"],"prefix":"10.1016","volume":"7","author":[{"given":"S.W.M.","family":"Lun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.S.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.K.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.W.K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2007.08.021_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","article-title":"Role of cytokines in rheumatoid arthritis","volume":"14","author":"Feldmann","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2007.08.021_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81109-5","article-title":"Rheumatoid arthritis","volume":"85","author":"Feldmann","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2007.08.021_bib3","first-page":"CD003785","article-title":"Infliximab for the treatment of rheumatoid arthritis","author":"Blumenauer","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.intimp.2007.08.021_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","article-title":"Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?","volume":"19","author":"Feldmann","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2007.08.021_bib5","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2007.08.021_bib6","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","article-title":"Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis","volume":"41","author":"Maini","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2007.08.021_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1359-6101(02)00018-7","article-title":"Cytokines and anti-cytokine biologicals in autoimmunity: present and future","volume":"13","author":"Andreakos","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2007.08.021_bib8","first-page":"ii11","article-title":"Pathogenesis of bone and cartilage destruction in rheumatoid arthritis","volume":"42","author":"Goldring","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2007.08.021_bib9","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.163.3.1521","article-title":"Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis","volume":"163","author":"Charles","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2007.08.021_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L","article-title":"Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis","volume":"43","author":"Taylor","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2007.08.021_bib11","first-page":"62","article-title":"Cytotoxicity of tumor necrosis factor-alpha for human umbilical vein endothelial cells","volume":"61","author":"Schuger","year":"1989","journal-title":"Lab Invest"},{"key":"10.1016\/j.intimp.2007.08.021_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00002281-200201000-00004","article-title":"New findings in pathogenesis of antineutrophil cytoplasm antibody-associated vasculitis","volume":"14","author":"Savage","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.intimp.2007.08.021_bib13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10067-005-0106-0","article-title":"Clinical significance of IL-18, IL-15, IL-12 and TNF-alpha measurement in rheumatoid arthritis","volume":"25","author":"Petrovic-Rackov","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.intimp.2007.08.021_bib14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/ard.61.8.723","article-title":"Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13","volume":"61","author":"Pittoni","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2007.08.021_bib15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s10067-006-0372-5","article-title":"Rapid improvement in rheumatoid arthritis patients on combination of methotrexate and infliximab: clinical and magnetic resonance imaging evaluation","volume":"26","author":"Tam","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.intimp.2007.08.021_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2007.08.021_bib17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/art.1780380602","article-title":"American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis","volume":"38","author":"Felson","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2007.08.021_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2249.1999.00766.x","article-title":"Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)","volume":"115","author":"Viallard","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.intimp.2007.08.021_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.intimp.2003.12.003","article-title":"Immunomodulatory effects of yun zhi and danshen capsules in health subjects-a randomized, double-blind, placebo-controlled, crossover study","volume":"4","author":"Wong","year":"2004","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2007.08.021_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1568010054022114","article-title":"Neutrophil-derived cytokines: potential therapeutic targets in inflammation","volume":"4","author":"Kasama","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.intimp.2007.08.021_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1620\/tjem.188.75","article-title":"The participation of IL-8 in the synovial lesions at an early stage of rheumatoid arthritis","volume":"188","author":"Takahashi","year":"1999","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.intimp.2007.08.021_bib22","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2007.08.021_bib23","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/1529-0131(199807)41:7<1258::AID-ART17>3.0.CO;2-1","article-title":"Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis","volume":"41","author":"Paleolog","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2007.08.021_bib24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00129804-200311000-00008","article-title":"Comprehensive nursing approach to infliximab infusion therapy","volume":"26","author":"Stone","year":"2003","journal-title":"J Infus Nurs"},{"key":"10.1016\/j.intimp.2007.08.021_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.clim.2005.04.010","article-title":"Regulation of p38 map kinase in CD4+ lymphocytes by infliximab therapy in patients with rheumatoid arthritis","volume":"116","author":"Garfield","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.intimp.2007.08.021_bib26","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1046\/j.1365-2036.2001.01119.x","article-title":"Infliximab for Crohn's disease","volume":"15","author":"Verspaget","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.intimp.2007.08.021_bib27","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0140-6736(00)02871-3","article-title":"Mechanisms in failure of infliximab for Crohn's disease","volume":"356","author":"Nikolaus","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2007.08.021_bib28","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.163.3.1521","article-title":"Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis","volume":"163","author":"Charles","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2007.08.021_bib29","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood.V84.7.2068.2068","article-title":"Leukocyte-endothelial adhesion molecules","volume":"84","author":"Carlos","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2007.08.021_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ncprheum0020","article-title":"Cytokine networks-towards new therapies for rheumatoid arthritis","volume":"1","author":"McInnes","year":"2005","journal-title":"Nat Clin Pract Rheumatol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576907002706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576907002706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T17:21:05Z","timestamp":1684084865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576907002706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":30,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S1567576907002706"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2007.08.021","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}